Alphamab Oncology's total assets for Q2 2025 were ¥2.36B, an increase of 5.23% from the previous quarter. HK:9966 total liabilities were ¥503.95M for the fiscal quarter, a 22.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.